|
2023 Conference Publication Patients from East Asia with acute severe ulcerative colitis have worse endoscopic severity but are more responsive to intravenous steroids than patients from Australasia: Preliminary results of the APAC-ASUC study in collaboration with the ANZIBDC and AOCCFernandes, R., Gilmore, R., Ruddick-Collins, L., Rice, K., Gazelakis, K., Moore, G., Vasudevan, A., Zhang, J., Wright, E., Schildkraut, T., Clark, N., Schultz, M., Brownson, A., Haifer, C., Bracken, L. M. L., Mahy, G., Swe, E., Lynch, K., Ngoi, B., Judge, C., Kim, D. H., Kim, H. S., Lee, H. S., Kim, K. O., Lee, Y. J., Kim, S-J, Lee, J., Song, E. M., Park, S. H. ... An, Y-K (2023). Patients from East Asia with acute severe ulcerative colitis have worse endoscopic severity but are more responsive to intravenous steroids than patients from Australasia: Preliminary results of the APAC-ASUC study in collaboration with the ANZIBDC and AOCC. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2023, Brisbane, QLD Australia, 2-5 September 2023. Richmond, VIC Australia: John Wiley & Sons. |
|
2023 Conference Publication Reduction of bowel wall thickness and doppler signals as eary as 36 hours predicts corticosteroid response in a multi-centre prospective cohort of acute severe ulcerative colitis: USUC study including genius cohortAn, Yoon-Kyo, Fernandes, Richard, Lindsay, Niamh, Khoo, Emi, Pham, Hai, Wong, Kam Fai, Thin, Lena, Goodsall, Thomas, Bryant, Robert V., Wright, Emily K., Smith, Rebecca, Friedman, Antony and Begun, Jakob (2023). Reduction of bowel wall thickness and doppler signals as eary as 36 hours predicts corticosteroid response in a multi-centre prospective cohort of acute severe ulcerative colitis: USUC study including genius cohort. Digestive Disease Week (DDW) 2023, Chicago, IL United States, 6-9 May 2023. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(23)03032-9 |
|
2023 Conference Publication Post-ustekinumab induction IL-12, IL-23, and ustekinumab levels are associated with clinical response in a multicentre prospective cohort study of Crohn's disease patients: results from the Aurora StudyAn, Yoon-Kyo, Lindsay, Niamh, Allan, Natalie, Khoo, Emi, Fernandes, Richard, Amiss, Anna, Pham, Hai, Wong, Kam Fai, Ooi, Soong-Yuan, Thin, Lena, Lightowler, Daniel, Connor, Susan J., Williams, Astrid-Jane, De Cruz, Peter, Suen, Christopher Li Wai, Kariyawasam, Viraj C., Mitrev, Nikola, Ghaly, Simon, Andrews, Jane M., Christensen, Britt, Sparrow, Miles, White, Lauren S., Bryant, Robert V., Ding, Nik S., Leong, Rupert, Van Langenberg, Daniel R., Seltenreich, Hansjoerg, Subramaniam, Kavitha, Radford-Smith, Graham L. and Begun, Jakob (2023). Post-ustekinumab induction IL-12, IL-23, and ustekinumab levels are associated with clinical response in a multicentre prospective cohort study of Crohn's disease patients: results from the Aurora Study. Digestive Disease Week (DDW), Chicago, IL United States, 6-9 May 2023. Philadelphia, PA United States: Elsevier. |
|
2023 Conference Publication Baseline cytokine levels and microbiome signatures are associted with clinical response following ustekinumab induction in a multi-centre prospective cohort study of crohn's disease patients: results from the aurora studyAn, Yoon-Kyo, Lindsay, Niamh, Allan, Natalie, Khoo, Emi, Fernandes, Richard, Amiss, Anna, Pham, Hai, Giri, Rabina, Ooi, Soong-Yuan, Thin, Lena, Lightowler, Daniel, Connor, Susan J., Williams, Astrid-Jane, De Cruz, Peter, Suen, Christopher Li Wai, Kariyawasam, Viraj C., Mitrev, Nikola, Ghaly, Simon, Andrews, Jane M., Christensen, Britt, Sparrow, Miles, White, Lauren S., Bryant, Robert V., Ding, Nik S., Leong, Rupert, Van Langenberg, Daniel R., Seltenreich, Hansjoerg, Subramaniam, Kavitha, Radford-Smith, Graham L. and Begun, Jakob (2023). Baseline cytokine levels and microbiome signatures are associted with clinical response following ustekinumab induction in a multi-centre prospective cohort study of crohn's disease patients: results from the aurora study. Digestive Disease Week (DDW), Chicago, IL United States, 6-9 May 2023. Philadelphia, PA United States: Elsevier. doi: 10.1016/S0016-5085(23)02531-3 |
|
2023 Conference Publication Reduction of bowel wall thickness and doppler signals as eary as 36 hours predicts corticosteroid response in a multi-centre prospective cohort of acute severe ulcerative colitis: USUC study including genius cohortAn, Yoon-Kyo, Fernandes, Richard, Lindsay, Niamh, Khoo, Emi, Pham, Hai, Wong, Kam Fai, Thin, Lena, Goodsall, Thomas, Bryant, Robert V., Wright, Emily K., Smith, Rebecca, Friedman, Antony and Begun, Jakob (2023). Reduction of bowel wall thickness and doppler signals as eary as 36 hours predicts corticosteroid response in a multi-centre prospective cohort of acute severe ulcerative colitis: USUC study including genius cohort. Digestive Disease Week (DDW), Chicago, IL United States, 6-9 May 2023. Philadelphia, PA United States: Elsevier. |
|
2023 Conference Publication Post-Ustekinumab induction IL-12, IL-13 and Ustekinumab levels are associated with clinical response in a multicentre prospective cohort study of Crohn's disease patients: results from the Aurora studyAn, Yoon-Kyo, Lindsay, Niamh, Allan, Natalie, Khoo, Emi, Fernandes, Richard, Amiss, Anna, Pham, Hai, Wong, Kam Fai, Ooi, Soong-Yuan, Thin, Lena, Lightowler, Daniel, Connor, Susan J., Williams, Astrid-Jane, De Cruz, Peter, Suen, Christopher Li Wai, Kariyawasam, Viraj C., Mitrev, Nikola, Ghaly, Dr Simon, Andrews, Jane M., Christensen, Britt, Sparrow, Miles, White, Lauren S., Bryant, Robert V., Ding, Nik S., Leong, Rupert, Van Langenberg, Daniel R., Seltenreich, Hansjoerg, Subramaniam, Kavitha, Radford-Smith, Graham L. and Begun, Jakob (2023). Post-Ustekinumab induction IL-12, IL-13 and Ustekinumab levels are associated with clinical response in a multicentre prospective cohort study of Crohn's disease patients: results from the Aurora study. Digestive Disease Week DDW / AGA Conference 2023, Chicago, IL United States, 6-9 May 2023. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(23)03564-3 |
|
2023 Conference Publication Post-ustekinumab induction IL12, IL23, and ustekinumab levels are associated with clinical response in a multi-centre prospective cohort study of Crohn's disease patients: results from the AURORA Study including ANZIBDC CohortAn, Y. K., Lindsay, N., Allan, N., Khoo, E., Fernandes, R., Amiss, A., Pham, H., Wong, K. F., Ooi, S. Y., Thin, L., Lightowler, D., Connor, S. J., Williams, A. J., De Cruz, P., Suen, C. Li Wai, Kariyawasam, V., Mitrev, N., Ghaly, S., Andrews, J. M., Christensen, B., Sparrow, M. P., White, L. S., Bryant, R. V., Ding, N., Leong, R., Van Langenberg, D., Seltenreich, H., Subramaniam, K., Radford-Smith, G. and Begun, J. (2023). Post-ustekinumab induction IL12, IL23, and ustekinumab levels are associated with clinical response in a multi-centre prospective cohort study of Crohn's disease patients: results from the AURORA Study including ANZIBDC Cohort. 18th Congress of ECCO, Copenhagen, Denmark, 1-4 March 2023. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ecco-jcc/jjac190.0793 |
|
2023 Conference Publication Reduction of bowel wall thickness and doppler signals as early as 36 hours predicts corticosteroid response in a multi-centre prospective cohort of Acute Severe Ulcerative Colitis: USUC Study including the GENIUS cohortAn, Y. K., Fernandes, R., Lindsay, N., Khoo, E., Pham, H., Wong, K. F., Thin, L., Goodsall, T., Bryant, R. V., Wright, E., Smith, R., Friedman, A., Begun, J. and Gastroenterology Network of Intestinal Ultrasound (GENIUS) (2023). Reduction of bowel wall thickness and doppler signals as early as 36 hours predicts corticosteroid response in a multi-centre prospective cohort of Acute Severe Ulcerative Colitis: USUC Study including the GENIUS cohort. 18th Congress of ECCO, Copenhagen, Denmark, 1-4 March 2023. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ecco-jcc/jjac190.0744 |
|
2022 Conference Publication Post-induction IL-12/23 levels correlate with clinical response and remission after ustekinumab in a multicenter prospective cohort study of patients with Crohn’s disease: Preliminary induction results of the AURORA study, including the Australia New Zealand IBD Consortium CohortAn,Yoon-Kyo, Lindsay, Niamh, Allan, Natalie, Khoo, Emi, Amiss, Anna, Moniruzzaman, Md, Fernandes, Richard, Ooi, Soong-Yuan J., Thin, Lena W.Y., Mstj, Daniel Lightowler, Connor, Susan, Williams, Astrid-Jane, De Cruz, Peter, Suen, Christopher Li Wai, Kariyawasam, Viraj C., Mitrev, Nicola, Ghaly, Simon, Andrews, Jane M., Christensen, Britt, Sparrow, Miles, White, Lauren, Bryant, Robert, Ding, Nik S., Leong, Rupert W., Van Langenberg, Daniel R., Seltenreich, Hans, Subramaniam, Kavitha, Radford-Smith, Graham and Begun, Jakob (2022). Post-induction IL-12/23 levels correlate with clinical response and remission after ustekinumab in a multicenter prospective cohort study of patients with Crohn’s disease: Preliminary induction results of the AURORA study, including the Australia New Zealand IBD Consortium Cohort. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2022, Sydney, NSW Australia, 9–11 September 2022. Richmond, VIC Australia: John Wiley & Sons. doi: 10.1111/jgh.15953 |
|
2022 Conference Publication Ocrelizumab-induced medically refractory fulminant colitis requiring colectomyMalloy, R., Fernandes, R., Begun, J. and An, Y-K (2022). Ocrelizumab-induced medically refractory fulminant colitis requiring colectomy. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2022, International Convention Centre Sydney (ICC Sydney), Sydney, NSW, Australia, 9 - 11 September 2022. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/jgh.15953 |
|
2022 Conference Publication Biologic-experienced ulcerative colitis: a distinct disease phenotypeFernandes, R., Llewelyn, J., Radford-Smith, G. and Croft, A. (2022). Biologic-experienced ulcerative colitis: a distinct disease phenotype. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2022, Sydney, NSW, Australia, 9 - 11 September 2022. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/jgh.15953 |
|
2020 Conference Publication Audit of response to conservative management in acute food bolusesConnolly, E., Bradbear, J., Fernandes, R., Pakneshan, S., Hewawasam, S., Vaux, L., Kasi, M., Hodgson, R., Pan, A. and Rahman, T. (2020). Audit of response to conservative management in acute food boluses. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2020, Virtual, 21 - 30 November 2020. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/jgh.15277 |
|
2020 Conference Publication A visual tool for hepatic osteodystrophy screening in patients with chronic liver diseaseDe'Ambrosis, S., Bradbear, J., Thompson, H., Fernandes, R., Pakneshan, S., Vaux, L., Hewawasam, S., Kasi, M., Pan, A., Hodgson, R. and Rahman, T. (2020). A visual tool for hepatic osteodystrophy screening in patients with chronic liver disease. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2020, Virtual, 21 - 30 November 2020. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/jgh.15269 |
|
2020 Conference Publication The application of Baveno VI criteria to improve value care and reduce risk exposure for patients with chronic liver diseaseVaux, L., Fernandes, R., Bradbear, J., Pakneshan, S., Thompson, H., Hewawasam, S., Hodgson, R., Pan, A., Kasi, M. and Rahman, T. (2020). The application of Baveno VI criteria to improve value care and reduce risk exposure for patients with chronic liver disease. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2020, Virtual, 21 - 30 November 2020. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/jgh.15269 |
|
2020 Conference Publication Colonoscopy surveillance workload before and after implementation of new National Health and Medical Research Council guidelinesPakneshan, S., Bradbear, J., Vaux, L., Fernandes, R., Hewawasam, S., Hodgson, R., Kasi, M., Pan, A., Vandeleur, A., Wright, E., Harch, J. and Rahman, T. (2020). Colonoscopy surveillance workload before and after implementation of new National Health and Medical Research Council guidelines. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2020, Virtual, 21 - 30 November 2020. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/jgh.15277 |
|
2020 Conference Publication Patients presenting with food boluses after hours on weekdays wait the longest for endoscopyFernandes, R., Sahar, P., Connolly, E., Bradbear, J., Hewawasam, S., Vaux, L., Hodgson, R., Kasi, M., Pan, A. and Rahman, T. (2020). Patients presenting with food boluses after hours on weekdays wait the longest for endoscopy. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2020, Virtual, 21 - 30 November 2020. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/jgh.15277 |
|
2020 Conference Publication Computed tomography colonography to assist with risk stratificationVaux, L., Fernandes, R., Pakneshan, S., Bradbear, J., Hewawasam, S., Vandeleur, A., Pan, A., Kasi, M., Hodgson, R. and Rahman, T. (2020). Computed tomography colonography to assist with risk stratification. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2020, Virtual, 21 - 30 November 2020. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/jgh.15273 |
|
2020 Conference Publication Steakhouse syndrome: male susceptibility to poorly chewed meatConnolly, E., Fernandes, R., Bradbear, J., Pakneshan, S., Vaux, L., Hewawasam, S., Kasi, M., Pan, A., Hodgson, R. and Rahman, T. (2020). Steakhouse syndrome: male susceptibility to poorly chewed meat. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2020, Virtual, 21 - 30 November 2020. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/jgh.15277 |
|
2020 Conference Publication Duodenal disaccharidase testing may not alter clinical managementSmith, O., Fernandes, R., Bradbear, J., Thompson, H., Pakneshan, S., Vaux, L., Pan, A., Kasi, M., Hewawasam, S., Hodgson, R. and Rahman, T. (2020). Duodenal disaccharidase testing may not alter clinical management. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2020, Virtual, 21 - 30 November 2020. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/jgh.15273 |
